...
Product Theater – CIMZIA® (certolizumab pegol): A Different Kind of Anti-TNF for Psoriatic Disease
June 8, 2019

Featuring Guest Faculty, Robert Casquejo, PA-C For Saturday morning’s product theater, Robert Casquejo, PA-C, presented information on the medication Cimzia. Cimzia is an FDA approved biologic treatment for adults with moderate to severe psoriasis and for treatment of adults with psoriatic arthritis. Cimzia is an injectable TNF blocker medication. According to Mr. Casquejo, Cimzia has …

...
Product Theater – TREMFYA® (guselkumab): A First-line Biologic with Clinical Data vs Adalimumab and Secukinumab
June 7, 2019

Featuring Guest Faculty, Jeffrey Johnson, PA-C For Friday afternoon’s product theater, Jeffrey Johnson, PA-C , discussed psoriasis and treatment with Tremfya. Mr. Johnson reminded the audience psoriasis is not just an inflammatory skin disease but a global inflammatory disease which can affect all organ systems. For example, patients with moderate to severe psoriasis are 54% …